PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through vertical integration, industry dominance and marking up the prices of specialty drugs.

The report specifically looked at the business practices of the Caremark Rx, Express Scripts and OptumRx, which are in turn owned by CVS Health, Cigna and UnitedHealth Group, respectively. These companies are considered the "Big 3" in the PBM industry, controlling roughly 60 percent of the market.

“The FTC staff’s second interim report finds that the three major pharmacy benefit managers hiked costs for a wide range of lifesaving drugs, including medications to treat heart disease and cancer,” FTC Chair Lina Khan said in a statement.

Khan said during an FTC open commission meeting to discuss the findings on Tuesday that the five-person commission had voted unanimously in favor of issuing the report.

According to the report, the "Big 3" PBMs marked up the prices of many specialty generic drugs by hundreds or thousands of percent.

Significantly marking up the prices 51 such drugs helped PBM-affiliated pharmacies generate $7.3 billion in revenue between 2017 and 2022. The commission noted these prices were in excess of the National Average Drug Acquisition Cost (NADAC) for these drugs.

As is noted in the report, there is no set definition for what specialty drugs are. The Office of Inspector General for the Department of Health and Human Services has previously said a product can be considered a specialty drug because it may be "expensive; be difficult to handle, monitor or administer; or treat rare, complex or chronic conditions."

The FTC found that 22 percent of specialty drugs dispensed by PBM-affiliated pharmacies were marked up by more than 1,000 percent while 41 percent were marked up between 100 and 1,000 percent. Among those drugs marked up by more than 1,000 percent, half of them were marked up by more than 2,000 percent.

In 2023, the top three PBMs dispensed the majority of specialty drugs in the U.S. at 68 percent, a double-digit hike from when it dispensed 54 percent of specialty drugs in 2016.

"Specialty generic drugs represented a growing profit center for the Big 3 PBMs and their affiliated pharmacies during our study period from 2017 through part of 2022," the report found.

"Given the combination of high reimbursement rates and large dispensing volumes, the Big 3 PBMs’ affiliated pharmacies generated significant and growing levels of revenue in excess of estimated acquisition cost (NADAC) on the most highly marked up specialty generic drugs during the study period, while the Big 3 PBMs also appeared to take in significant income from spread pricing on these drugs, in aggregate," the report continued, while noting plans sponsors and patients paid "substantially" more in that same time frame.

Antitrust attorney Austin Ownbey spoke on behalf of the Pharmaceutical Care Management Association (PCMA), a trade organization that represents PBMs, during the open commission meeting Tuesday.

"PCMA has significant concerns that a second interim report regarding specialty drugs is unlikely to be anything other than a piece of advocacy without substantiating evidence," said Ownbey. "Specialty drugs offer the most effective and, in some cases, the only treatment for illness and conditions that historically had few treatment options, including multiple sclerosis, cystic fibrosis, cancer and autoimmune disorders."

PBM practices have incurred significant bipartisan scrutiny in Congress. Sens. Elizabeth Warren (D-Mass.) and Josh Hawley (R-Mo.) as well as Reps. Jake Auchincloss (D-Mass.) and Diana Harshbarger (R-Tenn.) called on the FTC to issue its second interim staff report. The lawmakers said they expected the report would inform future legislation on PBMs.

Topics

‘Rising star’: Europe made more electricity from solar than coal in 2024

Report reveals solar power generated 11% of Europe’s electricity, surpassing coal at 10%. Europe made more electricity from sunshine than coal last year, a report has found, in what analysts called ...
The Guardian - 3h
Bills fans help raise more than $77,000 for Mark Andrews-backed charity after his drop in playoff loss

Mark Andrews dropped what would've been a game-tying 2-point conversion on Sunday in their playoff loss to the Bills.
Yahoo Sports - 23h
Evacuations lifted for more than 1,000 after fire erupts in California battery storage plant

About 1,500 people were instructed to leave Moss Landing and the Elkhorn Slough area.
NBC News - 4d
Top 3 drug insurers reaped billions as their drug middlemen inflated prices, FTC alleges

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ prescription price hikes of 1,000% or more.
NBC News - Jan. 14
‘Our computer sampler cost more than a house!’: how the Korgis made Everybody’s Got to Learn Sometime

‘I wrote it in 20 minutes one Sunday morning and there have now been more than 50 cover versions. My favourite is the brooding one Beck did for Eternal Sunshine of the Spotless Mind’. We’d had a ...
The Guardian - Jan. 13
L.A. wildfires to cost insurers more than $20 billion. Three companies are likely to foot most of the bill.

Allstate, Chubb and Travelers are likely to be the publicly traded insurance carriers most affected, as they are the most exposed to the California homeowners’ market.
MarketWatch - Jan. 10
L.A. wildfires have caused more than $135 billion in economic losses — and counting

Fires across Southern California are already one of the most damaging in the states history.
MarketWatch - Jan. 10
Mark Cuban: I'd rather own bitcoin than gold if something bad happens to the economy—'I think it has more value'

Billionaire investor Mark Cuban says bitcoin can function as a store of value and a currency in case of economic turmoil. It even has some advantages over gold.
CNBC - Jan. 8
Less than 1 in 1,000 adolescents received gender-affirming medications: Study

Less than 1 in 1,000 adolescents with commercial insurance received gender-affirming medication over a five-year period, according to a study released Monday. The researchers in the study surveyed ...
The Hill - Jan. 6
Here's why one of our favorite industrial stocks is up more than 3% Friday

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
CNBC - Jan. 3

PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC

Topics

Related

‘Rising star’: Europe made more electricity from solar than coal in 2024

Bills fans help raise more than $77,000 for Mark Andrews-backed charity after his drop in playoff loss

Evacuations lifted for more than 1,000 after fire erupts in California battery storage plant

Top 3 drug insurers reaped billions as their drug middlemen inflated prices, FTC alleges

‘Our computer sampler cost more than a house!’: how the Korgis made Everybody’s Got to Learn Sometime

L.A. wildfires to cost insurers more than $20 billion. Three companies are likely to foot most of the bill.

L.A. wildfires have caused more than $135 billion in economic losses — and counting

Mark Cuban: I'd rather own bitcoin than gold if something bad happens to the economy—'I think it has more value'

Less than 1 in 1,000 adolescents received gender-affirming medications: Study

Here's why one of our favorite industrial stocks is up more than 3% Friday

More from The Hill

Live updates: Trump talks to Sean Hannity in first interview since becoming president

Bishop who made plea to Trump says she won't apologize

RFK Jr. releases financial disclosure

Dimon defends Trump tariffs

Trump talks tough with Putin on ending Ukraine war

More in Politics

Live updates: Trump talks to Sean Hannity in first interview since becoming president

Who is in charge of the CDC right now? Nobody knows for sure

Stewart Rhodes, Oath Keepers leader freed by Trump, seen on Capitol Hill

Trump moves to fire or force out thousands of federal employees

Trump's pick to lead Commerce set for confirmation hearing